- Home
- OTLK vs FTEK Comparison
OTLK vs FTEK Comparison
Compare OTLK & FTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | FTEK |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Pollution Control Equipment |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 42.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OTLK | FTEK |
|---|---|---|
| Price | $0.40 | $1.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $3.83 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.8M | 178.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,425.11 | $9.16 |
| Revenue Next Year | $129.89 | $21.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $0.87 |
| 52 Week High | $3.39 | $3.65 |
Technical Indicators
Market Signals| Indicator | OTLK | FTEK |
|---|---|---|
| Relative Strength Index (RSI) | 32.18 | 46.43 |
| Support Level | $0.38 | $1.25 |
| Resistance Level | $0.53 | $1.48 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 8.74 | 56.52 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About FTEK Fuel Tech Inc.
Fuel Tech Inc is an technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.